The gain of oncogenicity or loss of tumor suppressor function of p53 due to its inactivation through missense mutations contributes to tumor aggressiveness and results in poor patient survival [13], [14], [15], [16], [17], [18], [19]. The gene discussed is TP53; the disease is neoplasm.